drosen32 t1_j5xbnrs wrote on January 26, 2023 at 5:02 AM Reply to comment by Sufficient-Ad6 in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken I’d be on the monthly vaccine plan if there was one. Permalink Parent 1
drosen32 t1_j5xbnrs wrote
Reply to comment by Sufficient-Ad6 in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
I’d be on the monthly vaccine plan if there was one.